| Date Filed | Type | Description |
| 10/13/2023 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials: |
| 10/05/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 10/05/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/05/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 10/04/2023 |
4
| Rider Michael J (Global General Counsel) has filed a Form 4 on RESMED INC|
Txns:
| Sold 25 shares
@ $145.92, valued at
$3.6k
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC|
Txns:
| Sold 5,675 shares
@ $183.1977, valued at
$1M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
| 08/16/2023 |
4
| Douglas Robert Andrew (President and COO) has filed a Form 4 on RESMED INC|
Txns:
| Sold 1,500 shares
@ $181.01, valued at
$271.5k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
10-K
| Annual Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits Interactive Data |
| 08/02/2023 |
4
| Rider Michael J (Global General Counsel) has filed a Form 4 on RESMED INC|
Txns:
| Sold 25 shares
@ $224.12, valued at
$5.6k
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
4
| Ghoshal Kaushik (President, SaaS Business) has filed a Form 4 on RESMED INC|
Txns:
| Sold 500 shares
@ $220, valued at
$110k
|
|
| 07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/06/2023 |
SC 13G/A
| RESMED INC reports a 5.6% stake in Nyxoah SA |
| 07/05/2023 |
4
| Rider Michael J (Global General Counsel) has filed a Form 4 on RESMED INC|
Txns:
| Sold 25 shares
@ $217.21, valued at
$5.4k
|
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/03/2023 |
3
| Rider Michael J (Global General Counsel) has filed a Form 3 on RESMED INC |
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC |
| 06/16/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC|
Txns:
| Sold 5,675 shares
@ $217.3949, valued at
$1.2M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
| 06/07/2023 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC|
Txns:
| Sold 1,500 shares
@ $219.79, valued at
$329.7k
|
|
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|